GO:0030488 tRNA methylation: Epitranscriptomic Regulation, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0030488 tRNA methylation is the posttranscriptional addition of methyl groups to specific residues in a tRNA molecule, a conserved epitranscriptomic process that fine-tunes tRNA stability and decoding.
• Methylation marks such as m1A, m7G, m5C, m2,2G and m6A are installed by dedicated tRNA methyltransferases and can alter tRNA folding, aminoacylation and codon-anticodon interactions.
• Mitochondrial translation depends on folate-dependent tRNA methylation, linking one-carbon metabolism directly to organellar protein synthesis.
• Dysregulated tRNA methylation contributes to cancer, mitochondrial disease, neurodevelopmental disorders and antibiotic persistence.
• tRNA methylation cross-talks with other RNA modifications such as queuosine, forming a complex regulatory layer.
• CRISPR knockout, point-mutation, knock-in and overexpression models are essential to dissect the causal roles of tRNA methyltransferases in disease.
Description
tRNA methylation (GO:0030488) is a fundamental posttranscriptional RNA modification in which methyl groups are covalently attached to specific nucleotides within transfer RNA molecules. This process is catalyzed by a diverse family of tRNA methyltransferases that use S-adenosylmethionine (SAM) as the methyl donor and target chemically distinct positions on the tRNA scaffold, including m1A, m7G, m5C, m2,2G and m6A. Because tRNAs are central to translation, these modifications directly influence tRNA stability, folding, aminoacylation and codon-anticodon pairing, thereby shaping the efficiency and fidelity of protein synthesis. Beyond housekeeping roles, tRNA methylation has emerged as a dynamic regulatory layer that connects cellular metabolism to gene expression. For example, mitochondrial translation requires folate-dependent tRNA methylation, tying one-carbon flux to organellar bioenergetics. In bacteria, tRNA methylation contributes to antibiotic resistance and persistence, highlighting its evolutionary importance. In humans, mutations or dysregulation of tRNA methyltransferases are increasingly linked to cancer, mitochondrial pathology and neurodevelopmental disorders. For researchers, GO:0030488 provides a precise ontological handle to study how methyl marks are written, read and erased on tRNA, and how these events influence physiology and disease. This article synthesizes authoritative QuickGO annotation and verified PubMed literature to outline the definition, mechanisms, key genes, disease links and experimental strategies for investigating tRNA methylation.
tRNA methylation At A Glance
| GO ID | GO:0030488 |
|---|---|
| GO term | tRNA methylation |
| Ontology | biological_process |
| Synonym | none |
| Definition | The posttranscriptional addition of methyl groups to specific residues in a tRNA molecule. |
| Major function | Modifies tRNA to regulate stability, folding, aminoacylation and translation |
| Methyl donor | S-adenosylmethionine (SAM) |
| Common marks | m1A, m7G, m5C, m2,2G, m6A |
| Representative enzymes | METTL1, TRMT6/61A, NSUN2, DNMT2, TRMT1, TRMT10C, FTSJ1 |
What Is GO:0030488?
GO:0030488 tRNA methylation is defined by the Gene Ontology as the posttranscriptional addition of methyl groups to specific residues in a tRNA molecule. In practice, this encompasses the enzymatic transfer of a methyl group from SAM to a target atom on a tRNA nucleotide, producing modified bases that can affect tRNA structure, stability and function.
Why Is tRNA methylation Important in Cell Biology?
tRNA methylation is important because it sits at the intersection of RNA modification, metabolism and translation control. Methyl marks influence tRNA stability and decoding, and their dysregulation has been linked to cancer, mitochondrial disease, neurodevelopmental disorders and microbial antibiotic persistence. Understanding GO:0030488 therefore provides mechanistic insight into how cells tune protein synthesis under stress and how epitranscriptomic lesions contribute to human pathology.
• Controls tRNA stability and folding, affecting the available pool of functional tRNAs.
• Modulates codon-anticodon interactions and translational fidelity.
• Links one-carbon metabolism to mitochondrial translation via folate-dependent methylation.
• Contributes to bacterial resistance and persistence to antibiotics.
• Is dysregulated in breast cancer, where METTL1-mediated m7G methylation restricts tumorigenesis.
• Mitochondrial tRNA methylation defects differentially contribute to mitochondrial pathology.
• Cross-talks with queuosine modification, expanding the epitranscriptomic regulatory network.
• Provides potential therapeutic targets for disorders of RNA modification.
• Serves as a biomarker candidate for cancers and mitochondrial diseases.
• Enables functional genomics studies using CRISPR models of tRNA methyltransferases.
What Happens During tRNA methylation?
Substrate recognition and methyl donor supply
In simple terms: The enzyme first finds the right tRNA and picks up a methyl group from SAM.
tRNA methyltransferases recognize specific sequence and structural features of their tRNA substrates, often using anticodon loop or elbow region determinants. The methyl donor SAM is generated through one-carbon metabolism, and folate-dependent pathways are required for mitochondrial tRNA methylation. This step ensures that methylation is coupled to cellular metabolic status.
Catalytic transfer of the methyl group
In simple terms: The enzyme attaches the methyl group to a specific atom on a tRNA base.
The catalytic domain of the methyltransferase transfers the methyl group from SAM to a target atom, producing modified bases such as m1A, m7G, m5C, m2,2G or m6A. Each enzyme has positional specificity, and the resulting mark can alter base pairing or local tRNA structure.
Effects on tRNA structure and stability
In simple terms: The new methyl mark changes how the tRNA folds and how long it survives.
Methylation can stabilize or destabilize tRNA depending on the mark and position. For example, m7G methylation affects tRNA stability and translation, and loss of METTL1-mediated m7G methylation impairs translation and restricts breast cancer tumorigenesis. These structural effects influence tRNA half-life and availability for translation.
Impact on translation and decoding
In simple terms: Methylated tRNAs can change how proteins are built.
Methyl marks can modulate aminoacylation, codon-anticodon pairing and ribosome interactions, thereby influencing translational efficiency and fidelity. In mitochondria, loss of tRNA methylation impairs organellar translation and contributes to pathology.
Cross-talk with other RNA modifications
In simple terms: Methylation does not happen in isolation; it interacts with other tRNA modifications.
tRNA methylation cross-talks with queuosine modification, and Dnmt2-dependent methylation can influence queuosine levels, forming a layered regulatory network. Such cross-talk expands the functional consequences of GO:0030488 beyond a single mark.
Key Genes Involved in GO:0030488 tRNA methylation
The following genes encode enzymes and factors that write, regulate or respond to tRNA methylation marks.
| Gene | Major Role | Research Relevance |
|---|---|---|
| METTL1 | Catalyzes m7G methylation on tRNA | Linked to translation control and breast cancer tumorigenesis |
| WDR4 | Partner of METTL1 for m7G methylation | Required for METTL1 stability and tRNA methylation |
| TRMT6 | Component of m1A tRNA methyltransferase complex | Involved in tRNA m1A modification and translation |
| TRMT61A | Catalytic subunit for tRNA m1A methylation | Regulates tRNA structure and translation |
| NSUN2 | Catalyzes m5C methylation on tRNA | Implicated in neurodevelopmental disorders and cancer |
| DNMT2 | Catalyzes m5C methylation on tRNA | Cross-talks with queuosine modification |
| TRMT1 | Catalyzes m2,2G methylation on tRNA | Required for tRNA stability and translation |
| TRMT10C | Catalyzes m1A methylation in mitochondrial tRNA | Linked to mitochondrial translation defects |
| FTSJ1 | Catalyzes 2'-O-methylation on tRNA | Associated with intellectual disability |
| TRMT5 | Catalyzes m1G methylation on tRNA | Affects mitochondrial translation |
| MTO1 | Modifies mitochondrial tRNA wobble position | Mitochondrial disease relevance |
| GTPBP3 | Modifies mitochondrial tRNA wobble position | Mitochondrial disease relevance |
| ALKBH1 | tRNA demethylase for m1A | Regulates tRNA methylation dynamics |
| FTO | tRNA demethylase for m6A | Links tRNA methylation to metabolism |
| METTL3 | Writer of m6A on tRNA and mRNA | Broad epitranscriptomic regulator |
| METTL14 | Partner of METTL3 | Supports m6A deposition |
| WTAP | Adapter for m6A machinery | Modulates m6A on tRNA |
How Is tRNA methylation Regulated?
tRNA methylation is regulated at multiple levels. The availability of SAM and one-carbon metabolites controls methyl donor supply, as shown by folate-dependent mitochondrial tRNA methylation. Expression levels and stability of methyltransferases such as METTL1/WDR4 determine mark abundance. Demethylases including ALKBH1 and FTO can remove methyl marks, adding reversibility. Cross-talk with queuosine modification further modulates the landscape. Together, these layers integrate metabolic, transcriptional and epitranscriptomic signals to tune tRNA methylation.
tRNA methylation and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| METTL1 | Breast cancer tumorigenesis | Knockout and overexpression in breast cancer cell lines |
| TRMT10C | Mitochondrial pathology | Point-mutation knock-in in mitochondrial disease models |
| NSUN2 | Neurodevelopmental disorders | Knockout in neuronal cell models |
| FTSJ1 | Intellectual disability | Knock-in of patient mutations in cell lines |
| DNMT2 | Queuosine cross-talk and stress response | Knockout in stress-challenged cells |
tRNA methylation in cancer
Dysregulated tRNA methylation contributes to cancer biology. METTL1-mediated m7G methylation and translational dysfunction restrict breast cancer tumorigenesis by fueling cell cycle blockade, indicating that loss of this mark can promote or inhibit tumor growth depending on context. Broader reviews highlight tRNA methylation as a therapeutic target in oncology.
Mitochondrial disease and tRNA methylation
Mitochondrial translation requires folate-dependent tRNA methylation, and defects in this process cause mitochondrial pathology. Post-transcriptional methylation of mitochondrial tRNA differentially contributes to mitochondrial pathology, with distinct marks producing different phenotypic outcomes.
Neurodevelopmental and other disorders
Mutations in tRNA methyltransferases such as NSUN2 and FTSJ1 are associated with neurodevelopmental disorders and intellectual disability. These findings link GO:0030488 to brain development and cognitive function.
Bacterial resistance and persistence
tRNA methylation provides an unexpected link to bacterial resistance and persistence to antibiotics, suggesting that methyl marks can influence antibiotic tolerance. This has implications for infectious disease research.
From tRNA methylation-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of METTL1 affect tRNA m7G and translation? | METTL1 knockout cell line |
| Does a specific point mutation in TRMT10C impair mitochondrial translation? | Point-mutation knock-in |
| Can wild-type tRNA methyltransferase rescue a disease phenotype? | Knock-in or overexpression |
| Where does the methyltransferase localize in cells? | Tagged knock-in with fluorescent tag |
| Which tRNAs are methylated under stress? | Overexpression of tagged enzyme plus RNA-seq |
| Does demethylase loss alter tRNA methylation dynamics? | Knockout of ALKBH1 or FTO |
How to Study the tRNA methylation Process
| Method | What It Measures | Typical Application |
|---|---|---|
| m1A-seq | m1A methylation sites | Mapping tRNA m1A marks |
| m7G-seq | m7G methylation sites | Mapping tRNA m7G marks |
| Ribo-seq | Ribosome occupancy and translation efficiency | Assessing translational impact |
| Polysome profiling | Translation status | Validating Ribo-seq findings |
| Mass spectrometry | Protein interactions and modifications | Identifying methyltransferase complexes |
| Fluorescence microscopy | Subcellular localization | Visualizing tagged enzymes |
| CRISPR knockout | Gene function loss | Testing causality of methyltransferases |
| CRISPR knock-in | Precise mutation introduction | Modeling patient variants |
RNA sequencing and modification mapping
RNA-seq and specialized modification mapping techniques such as m1A-seq, m7G-seq and bisulfite-based methods can identify methylated tRNA residues and quantify changes upon genetic perturbation. These approaches are essential to link genotype to epitranscriptotype.
Ribosome profiling and translation assays
Ribo-seq measures ribosome occupancy and translation efficiency, revealing how tRNA methylation affects protein synthesis. Polysome profiling and luciferase reporter assays complement these measurements.
Proteomics and interactomics
Mass spectrometry-based proteomics can identify methyltransferase complexes and quantify tRNA modification enzymes. Affinity purification coupled to mass spectrometry reveals interacting partners such as METTL1-WDR4.
Imaging and localization
Fluorescence microscopy of tagged tRNA methyltransferases or modified tRNA probes can reveal subcellular localization, including mitochondrial versus cytoplasmic distribution.
How CRISPR Can Be Used to Study GO:0030488 tRNA methylation
Knockout
CRISPR knockout of tRNA methyltransferases such as METTL1 or NSUN2 eliminates specific methyl marks, enabling loss-of-function studies on tRNA stability, translation and disease phenotypes.
Point Mutation
Point-mutation knock-in can model patient-derived missense variants in genes like TRMT10C or FTSJ1, revealing how single amino acid changes alter catalytic activity and contribute to mitochondrial or neurodevelopmental disease.
Knock-in
Knock-in of tagged or reporter alleles allows precise tracking of tRNA methyltransferase expression, localization and dynamics in live cells.
Overexpression
Overexpression of wild-type or mutant tRNA methyltransferases can test gain-of-function effects, rescue experiments and interactions with translation machinery.
How EDITGENE Supports tRNA methylation Research
Researchers studying tRNA methylation-related genes often need to determine whether a candidate gene is causally involved in a specific phenotype, and CRISPR-based models provide the most direct route to that answer. EDITGENE offers a comprehensive suite of services to generate and characterize such models.
Contact EDITGENE today to design your custom CRISPR model for tRNA methylation research.
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| NSUN2 Knockout HEK293 Cell Line | EDJ-KQ174 | Human | 54888 | Details Get a Quote |
| THUMPD3 Knockout HEK293 Cell Line | EDJ-KQ2976 | Human | 25917 | Details Get a Quote |
| TRDMT1 Knockout HEK293 Cell Line | EDJ-KQ4474 | Human | 1787 | Details Get a Quote |
| TARBP1 Knockout HEK293 Cell Line | EDJ-KQ5885 | Human | 6894 | Details Get a Quote |
| LCMT2 Knockout HEK293 Cell Line | EDJ-KQ6771 | Human | 9836 | Details Get a Quote |
| FTSJ1 Knockout HEK293 Cell Line | EDJ-KQ8141 | Human | 24140 | Details Get a Quote |
| NSUN6 Knockout HEK293 Cell Line | EDJ-KQ8795 | Human | 221078 | Details Get a Quote |
| TYW3 Knockout HEK293 Cell Line | EDJ-KQ9022 | Human | 127253 | Details Get a Quote |
| METTL6 Knockout HEK293 Cell Line | EDJ-KQ9279 | Human | 131965 | Details Get a Quote |
| THUMPD2 Knockout HEK293 Cell Line | EDJ-KQ9561 | Human | 80745 | Details Get a Quote |
| GTPBP3 Knockout HEK293 Cell Line | EDJ-KQ10174 | Human | 84705 | Details Get a Quote |
| BCDIN3D Knockout HEK293 Cell Line | EDJ-KQ10408 | Human | 144233 | Details Get a Quote |
| ALKBH8 Knockout HEK293 Cell Line | EDJ-KQ10786 | Human | 91801 | Details Get a Quote |
| TRMT44 Knockout HEK293 Cell Line | EDJ-KQ10825 | Human | 152992 | Details Get a Quote |
| TRMO Knockout HEK293 Cell Line | EDJ-KQ11132 | Human | 51531 | Details Get a Quote |
- 1
- 2
- Next Page »
Frequently Asked Questions About tRNA methylation
What is tRNA methylation?
tRNA methylation is the posttranscriptional addition of methyl groups to specific residues in a tRNA molecule, as defined by GO:0030488.
What genes are involved in tRNA methylation?
Key genes include METTL1, WDR4, TRMT6, TRMT61A, NSUN2, DNMT2, TRMT1, TRMT10C, FTSJ1 and TRMT5.
What is the GO ID for tRNA methylation?
The GO ID is GO:0030488.
How does tRNA methylation affect translation?
Methyl marks influence tRNA stability, aminoacylation and codon-anticodon pairing, thereby modulating translational efficiency and fidelity.
Is tRNA methylation linked to cancer?
Yes, METTL1-mediated m7G methylation and translational dysfunction restrict breast cancer tumorigenesis, and other tRNA methyltransferases are implicated in cancer.
What diseases are associated with tRNA methylation defects?
Mitochondrial pathology, neurodevelopmental disorders, intellectual disability and cancer have been linked to tRNA methylation defects.
How can I study tRNA methylation in the lab?
Common methods include m1A-seq, m7G-seq, Ribo-seq, polysome profiling, mass spectrometry and CRISPR knockout or knock-in models.
What is the role of folate in tRNA methylation?
Folate-dependent one-carbon metabolism supplies methyl groups for mitochondrial tRNA methylation, which is required for mitochondrial translation.
Does tRNA methylation cross-talk with other modifications?
Yes, Dnmt2-dependent tRNA methylation cross-talks with queuosine modification.
Can CRISPR be used to model tRNA methylation disorders?
Yes, CRISPR knockout, point-mutation knock-in and overexpression models are widely used to study tRNA methyltransferase function and disease.
Conclusion
GO:0030488 tRNA methylation is a central epitranscriptomic process that regulates tRNA function and translation, with far-reaching implications for cancer, mitochondrial disease, neurodevelopmental disorders and microbial antibiotic persistence. Understanding its mechanisms, key enzymes and regulatory layers provides a foundation for therapeutic targeting and biomarker development. CRISPR-based models are indispensable for dissecting the causal roles of tRNA methyltransferases. EDITGENE provides end-to-end services, from knockout and point-mutation models to library screening and bioinformatics, to accelerate research on tRNA methylation and its associated diseases.
References
- 1. Nau F. 1976. The methylation of tRNA.. Biochimie 58(6):629-45 PMID: 782564
- 2. Maharjan S et al.. 2024. Post-transcriptional methylation of mitochondrial-tRNA differentially contributes to mitochondrial pathology.. Nat Commun 15(1):9008 PMID: 39424798
- 3. Wu Z et al.. 2024. Methylation modifications in tRNA and associated disorders: Current research and potential therapeutic targets.. Cell Prolif 57(9):e13692 PMID: 38943267
- 4. Wang S et al.. 2026. tRNA methylation: functional insights and epitranscriptomic regulation.. Cell Commun Signal 24(1) PMID: 42351149
- 5. Hou YM et al.. 2020. tRNA methylation: An unexpected link to bacterial resistance and persistence to antibiotics and beyond.. Wiley Interdiscip Rev RNA 11(6):e1609 PMID: 32533808
- 6. Du D et al.. 2024. METTL1-mediated tRNA m(7)G methylation and translational dysfunction restricts breast cancer tumorigenesis by fueling cell cycle blockade.. J Exp Clin Cancer Res 43(1):154 PMID: 38822363
- 7. Morscher RJ et al.. 2018. Mitochondrial translation requires folate-dependent tRNA methylation.. Nature 554(7690):128-132 PMID: 29364879
- 8. Ehrenhofer-Murray AE. 2017. Cross-Talk between Dnmt2-Dependent tRNA Methylation and Queuosine Modification.. Biomolecules 7(1) PMID: 28208632
